Advertisement

Disease Outbreaks in Africa and the Response of African Governments

  • Oyewale Tomori
Chapter

Abstract

Sub-Saharan Africa is prone to outbreaks of emerging and re-emerging infectious diseases, especially those transmitted between vertebrate animals and humans. Some of these diseases include: Ebola, Rift Valley Fever, and plague. In recent years, a number of sub-Saharan African countries have experienced outbreaks of either Ebola or Lassa fever, which tend to spread across national borders. Yet, the reaction of governments in many of the affected African countries has often been characterized by an inability to promptly, effectively, and efficiently address these outbreaks. In this chapter we discuss the role of African governments in the fight against emerging and re-emerging infectious diseases.

References

  1. Abubakar, A. A., Sambo, M. N., Idris, S. H., Sabitu, K., & Nguku, P. (2013). Assessment of integrated disease surveillance and response strategy implementation in selected Local Government Areas of Kaduna state. Annals of Nigerian Medicine, 7(1), 14–19.CrossRefGoogle Scholar
  2. Adubifa, A. O. (2004). An assessment of science and technology capacity building in sub-Saharan Africa (Special Paper Series 19). Nairobi: African Technology Policy Studies Network (ATPS).Google Scholar
  3. African Union. (2017). OAU/AU treaties, conventions, protocols & charters. https://au.int/en/treaties. Accessed 19 Sept 2017.
  4. Agbo, C. (2013). Nigeria: New Abuja city gate to gulp N64 billion. http://allafrica.com/stories/201310150454.html. Accessed 21 Dec 2017.
  5. AIDS and Rights Alliance for Southern Africa. (2014). The right to health. Available at: www.arasa.info/index.php/info/fact-sheets. Accessed 26 Jan 2019.
  6. Alchon, S. A. (2003). A pest in the land: New world epidemics in a global perspective (p. 21). University of New Mexico Press. ISBN:0-8263-2871-7.
  7. Bell, B. P., Damon, I. K., Jernigan, D. B., Kenyon, T. A., Nichol, S. T., O’Connor, J. P., & Tapperoet, J. W. (2016). Overview, control strategies, and lessons learned in the CDC response to the 2014–2016 Ebola epidemic. MMWR Supplement, 65(3), 4–11.CrossRefGoogle Scholar
  8. CDC. (2015). Lassa fever. https://www.cdc.gov/vhf/lassa. Accessed 19 Dec 2017.
  9. CDC. (2017). Plague. https://www.cdc.gov/plague/. Accessed 19 Dec 2017.
  10. CDC. (2017a). Yellow fever timeline of activities. https://www.cdc.gov/travel-training/local/HistoryEpidemiologyandVaccination/HistoryTimelineTranscript.pdf. Accessed 21 Dec 2017.
  11. CDC. (2017b). Ebola virus disease. https://www.cdc.gov/vhf/ebola. Accessed 21 Dec 2017.
  12. CDC. (2017c). Outbreaks chronology- Ebola virus disease. https://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html#modalIdString_outbreaks. Accessed 21 Dec 2017.
  13. Daszak, P., Zambrana-Torrelio, C., Bogich, T. L., Fernandez, M., Epstein, J. H., Murray, K. A., & Hamilton, H. (2012). Interdisciplinary approaches to understanding disease emergence: The past, present, and future drivers of Nipah virus emergence. PNAS, 110(Suppl 1), 3681–3688.PubMedGoogle Scholar
  14. Economic Commission for Africa. (1997). ECA First African Governance Forum. http://www.africa.upenn.edu/Urgent_Action/apic_72097.html. Accessed 19 Sept 2017.
  15. Fisher-Hoch, S. P., Tomori, O., Nasidi, A., Perez-Oronoz, G. I., Fakile, Y., Hutwagner, L., & McCormick, J. B. (1995). Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice. British Medical Journal, 311(7009), 857–859.CrossRefGoogle Scholar
  16. Formenty, P. (2015). Ebola diaries: First signals–March 2014. http://www.who.int/features/2015/ebola-diaries-formenty/en/. Accessed 19 Dec 2017.
  17. Garske, T., Van Kerkhove, M. D., Yactayo, S., Ronveaux, O., Lewis, R. F., Staples, J. E., Perea, W., Ferguson, N. M., & Committee, Y. F. E. (2014). Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data. PLoS Medicine, 11(5), e1001638.CrossRefGoogle Scholar
  18. Great Britain Local Government Board. (1893). Further report and papers on epidemic influenza, 1889–92: With an introduction by the medical officer of the Local Government Board. H. M Stationery Office.Google Scholar
  19. Greenwood, B. M. (1995). From the Director: Gambia Medical Research Council Unit; Annual Report for 1995.Google Scholar
  20. Grépin, K. A. (2015). International donations to the Ebola virus outbreak: Too little, too late? BMJ, 350, h376.CrossRefGoogle Scholar
  21. Haddow, A. J. (2012). The Natural History of Yellow Fever in Africa. Proceedings of the Royal Society of Edinburgh Section B: Biology, 70(03), 191–227.CrossRefGoogle Scholar
  22. Hays J. N. (2005). Epidemics and pandemics: Their impacts on human history (pp. 513). Santa Barbara: ABC-CLIO.Google Scholar
  23. Horn, D. W. (1951). The epidemic of cerebrospinal fever in the northern provinces of Nigeria, 1949–1950. Journal Royal Sanitary Institute, 71(5), 573–589.CrossRefGoogle Scholar
  24. Mohammed, I., Nasidi, A., Alkali, A. S., Garbati, M. A., Ajayi-Obe, E. K., Audu, K. A., Abdulmumini, U., & Suleiman Abdullahi, S. (2000). A severe epidemic of meningococcal meningitis in Nigeria May 2000. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94(3), 265–270.CrossRefGoogle Scholar
  25. Muyembe-Tamfum, J. J., Mulangu, S., Masumu, J., Kayembe, J. M., Kemp, A., & Paweska, J. T. (2012). Ebola virus outbreaks in Africa: Past and present. The Onderstepoort Journal of Veterinary Research, 79, 6–13.CrossRefGoogle Scholar
  26. Nierle, T., & Jochum, B. (2014). Ebola: The failures of the international outbreak response. http://www.msf.org/article/ebola-failures-internationaloutbreak-response. Accessed 21 Dec 2017.
  27. Nigeria Centre for Disease Control. (2013). Federal Ministry of Health–Weekly Epidemiological Report: 2:52.Google Scholar
  28. Nigeria Centre for Disease Control. (2014). Federal Ministry of Health–Weekly Epidemiological Report: 4 (1).Google Scholar
  29. Nigeria Centre for Disease Control. (2015). Federal Ministry of Health – Weekly Epidemiological Report. 4: 52.Google Scholar
  30. Nigeria Centre for Disease Control. (2016a) Federal Ministry of Health – Weekly Epidemiological Report: 6:5.Google Scholar
  31. Nigeria Centre for Disease Control. (2016b). Federal Ministry of Health Weekly Epidemiology Report: 6:49.Google Scholar
  32. Nigeria Centre for Disease Control. (2017a). Federal Ministry of Health Lassa fever outbreak weekly Situation Report No. 46–December 1, 2017.Google Scholar
  33. Nigeria Centre for Disease Control. (2017b). Federal Ministry of Health – Nigeria Meningitis Outbreak, situation as of week ending 28 April 2017.Google Scholar
  34. OAU. (2001). Abuja declaration on HIV/AIDS, tuberculosis and other related infectious diseases-OAU/SPS/ABUJA/3. http://www.un.org/ga/aids/pdf/abuja_declaration.pdf. Accessed 19 Dec 2017.
  35. Olajide, A. (2010). Ten year review: Abuja Declaration on health financing in Africa. http://www.who.int/pmnch/media/membernews/2011/20110329_abujadeclaration.pdf. Accessed 18 Dec2017.
  36. Patterson, K. D., & Pyle, G. F. (1991). The geography and mortality of the 1918 influenza pandemic. Bulletin of the History of Medicine, 65(1), 4–21.PubMedGoogle Scholar
  37. Paul W. E. (2008). Fundamental immunology (pp. 1603). Philadelphia: Lippincott Williams & Wilkins.Google Scholar
  38. Paye-Layleh, J. (2015). Liberia audit report questions $673,000 in Ebola spending. http://www.nytimes.com/aponline/2015/04/15/world/africa/ap-af-ebola-westafrica.html?_r=0. Accessed 21 Dec 2017.
  39. Reuters. (2017). Ebola victims sue Sierra Leone government over mismanaged funds. https://www.reuters.com/article/us-health-ebola-leone/ebola-victims-sue-sierra-leone-government-over-mismanaged-funds-idUSKBN1E92NE. Accessed 21 Dec 2017.
  40. Richmond, J. K., & Baglole, D. J. (2003). Lassa fever: Epidemiology, clinical features and social consequences. The BMJ, 327(7426), 1271–1275.CrossRefGoogle Scholar
  41. SAGE. (2014). Roll out of the meningococcal A conjugate vaccine through mass vaccination campaigns in countries of the African meningitis belt current status, vaccine coverage, epidemiological and economic impact. http://www.who.int/immunization/sage/meetings/2014/october/2.DJINGAREY_Session6_SAGE_Oct2014_FINAL_21Oct2014.pdf. Accessed 12 Dec 2017.
  42. Sahid, J. S. (2015). Sierra Leone’s missing Ebola millions. http://www.irinnews.org/analysis/2015/03/30. Accessed 20 Dec 2017.
  43. Tomori, O. (2004). Yellow fever: The recurring plague. Critical Reviews in Clinical Laboratory Sciences, 41(4), 391–427.CrossRefGoogle Scholar
  44. Tomori, O. (2014). Winning the battle against emerging pathogens. A Nigerian Response. Bulletin of the Atomic Scientists, 70, 14–17.CrossRefGoogle Scholar
  45. Tomori, O. (2015a). Will Africa’s future epidemic ride on forgotten lessons from the Ebola epidemic? BMC Medicine, 13, 116.  https://doi.org/10.1186/s12916-015-0359-7.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Tomori, O. (2015b). Epidemiology and risk of yellow fever in current context. http://www.who.int/immunization/sage/meetings/2016/october/Session11-Part1-Epidemiology-and-risk-of-yellow-fever-in-current-context.pdf?ua=1. Accessed 25 Jan 2019.
  47. University of Maryland Medical Center. (1999). Plague of Athens: Another medical mystery solved at University of Maryland. https://www.newswise.com//articles/plague-of-athens-medical-mystery-may-be-solved. Accessed 19 Dec 2017.
  48. Vainio, J., & Cutts, F. (1998). Yellow fever. Geneva: World Health Organization (document WHO/EPI/GEN/98.11).Google Scholar
  49. Vittozzi, K. (2017). 400,000 children in north-east Nigeria at risk of severe acute malnutrition. https://www.unicef.org/infobycountry/nigeria_94178.html. Accessed 21 Dec 2017.
  50. Walker, P. (2010). Senegalese president unveils £17m African Renaissance statue. The Guardian. www.theguardian.com/world/2010/apr/04/senegal-african-renaissancestatue. Accessed 21 Dec 2017.
  51. WHO. (2005). Enhanced surveillance of epidemic meningococcal meningitis in Africa: A three-year experience. http://www.who.int/wer/2005/wer8037.pdf. Accessed 21 Dec 2017.
  52. WHO. (2010). Yellow fever initiative – providing an opportunity of a lifetime. Geneva: World Health Organization. http://www.who.int/csr/disease/yellowfev/YFIbrochure.pdf. Accessed 19 Dec 2017.
  53. WHO. (2014). Meningococcal disease control in countries of the African meningitis belt. http://www.who.int/wer/2015/wer9013.pdf?ua=1. Accessed 21 Dec 2017.
  54. WHO. (2015). Meningococcal disease control in countries of the African meningitis belt. http://www.who.int/wer/2016/wer9116.pdf?ua=1. Accessed 21 Dec 2017.
  55. WHO. (2016a). Yellow fever. http://www.who.int/csr/disease/yellowfev/en/. Accessed 21 Dec 2017.
  56. WHO. (2016b). Weekly epidemiological record, 31 March 2017. 92(13): 145–164. http://apps.who.int/iris/bitstream/10665/254901/1/WER9213.pdf?ua=1. Accessed 21 Dec 2017.
  57. WHO. (2016c). Public financing for health in Africa: From Abuja to the SDGs. https://apps.who.int/iris/bitstream/handle/10665/249527/WHO-HIS-HGF-Tech.Report-16.2-eng.pdf?sequence=1. Accessed 26 Jan 2019.
  58. WHO. (2017a). Cholera count reaches 500 000 in Yemen. http://www.who.int/mediacentre/news/releases/2017/cholera-yemen-mark/en/. Accessed 21 Dec 2017.
  59. WHO. (2017c). Ebola ça suffit!- Phase III vaccine trial in Guinea. http://www.who.int/medicines/ebola-treatment/q-a_ebola-ca-suffit/en. Accessed 21 Dec 2017.
  60. WHO. (2017d). Meningococcal meningitis. http://www.who.int/mediacentre/factsheets/fs141/en/. Accessed 21 Dec 2017.
  61. WHO. (2018). Ebola virus disease: Democratic Republic of Congo external situation report 7. https://apps.who.int/iris/bitstream/handle/10665/272728/SITREP-EVD-DRC-20180601-eng.pdf?sequence=1&isAllowed=y. Accessed 01 June 2018.
  62. WHO-AFRO. (2017a). Weekly bulletin on outbreaks and other emergencies week 50. http://apps.who.int/iris/bitstream/10665/259709/1/OEW50-1015122017.pdf. Accessed 21 Dec 2017.
  63. WHO-AFRO. (2017b). Regional committee sessions. http://www.afro.who.int/about-us/governance. Accessed 19 Sept 2017.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Oyewale Tomori
    • 1
  1. 1.Nigerian Academy of ScienceUniversity of LagosLagosNigeria

Personalised recommendations